Pure Global

"Daishoulin" tumor marker CA 125 II radioimmunoassay reagent - Taiwan Registration 5903a46b87e8041d5a6e6cc1170367ed

Access comprehensive regulatory information for "Daishoulin" tumor marker CA 125 II radioimmunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5903a46b87e8041d5a6e6cc1170367ed and manufactured by DIASORIN INC.;;DIASORIN S.P.A.. The authorized representative in Taiwan is TAIWAN LIFE SUPPORT SYSTEMS INC..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
5903a46b87e8041d5a6e6cc1170367ed
Registration Details
Taiwan FDA Registration: 5903a46b87e8041d5a6e6cc1170367ed
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Daishoulin" tumor marker CA 125 II radioimmunoassay reagent
TW: โ€œไปฃ้ฆ–ๆž—โ€่…ซ็˜คๆจ™่จ˜ CA 125 II ๆ”พๅฐ„ๅ…็–ซๅˆ†ๆž่ฉฆๅŠ‘
Risk Class 2
Cancelled

Registration Details

5903a46b87e8041d5a6e6cc1170367ed

DHAS0601628000

Company Information

Italy;;United States

Product Details

In vitro testing methods were used to quantitatively detect the content of CA 125 (OC 125 defined antigen) in serum and EDTA plasma and heparin plasma.

C Immunology and microbiology

C.6010 ่…ซ็˜ค็›ธ้—œๆŠ—ๅŽŸๅ…็–ซ่ฉฆ้ฉ—็ณป็ตฑ

Input;; Consent letter must be attached to the import (consent from the Atomic Energy Commission must be obtained for each import)

Dates and Status

Mar 31, 2006

Mar 31, 2011

Nov 27, 2012

Cancellation Information

Logged out

่จฑๅฏ่ญ‰ๅทฒ้€พๆœ‰ๆ•ˆๆœŸ